Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report details specific transactions in the company's own shares conducted under a share buyback programme announced on March 28, 2025. Haleon's portfolio includes major brands such as Advil, Sensodyne, Panadol, and Centrum across categories including Oral Health, Pain Relief, and Respiratory Health.
Key Financial Metrics and Share Transactions
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity and capital structure updates:
- Transaction 1 (March 28, 2025): Purchased 581,885 shares for cancellation. Price range: 384.00p to 391.20p. VWAP: 388.51p.
- Transaction 2 (March 31, 2025): Purchased 831,399 shares for cancellation. Price range: 387.70p to 392.80p. VWAP: 391.20p.
- Total Shares Purchased: 1,413,284 shares.
- Registered Share Capital (post-settlement): 9,038,156,791 ordinary shares of £0.01 each.
- Treasury Shares: 4,080,205 shares held.
- Voting Shares: 9,034,076,586 ordinary shares with voting rights.
Material Changes
The primary material change is the reduction in the number of outstanding shares with voting rights due to the cancellation of repurchased shares. The registered share capital decreased from 9,038,988,190 to 9,038,156,791 following the settlement of the April 1 transaction. No other operational or financial changes are reported in this document.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of risks and contingencies. It strictly reports historical share transaction data in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014).
Investor Verification Checklist
- Verify the total number of shares repurchased and cancelled against the company's latest quarterly report.
- Confirm the current number of voting shares (9,034,076,586) for disclosure threshold calculations under FCA rules.
- Review the full trade breakdown links provided in the filing for granular transaction data.
- Check the company's website (www.haleon.com/investors) for the complete status of the Buyback Programme.